despite neutral imaging results, adalimumab did improve other key markers of inflammation in the blood including glyca, crp, tnf, and il-6. . . .
-
.
�defending the crown� is another way to put it. the king may make mistakes, he may commit heinous offenses, but he is the king, and therefore his position must remain secure. . .
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .